secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2026-02-11T23:59:59+00:00
Accession:  0001213900-26-014878
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical grants CEO 200K and CFO 15K options at $0.53
----------------------------------------------------------

- CEO Brent Lucas received options for 200,000 shares; Interim CFO Robert Potashnick received 15,000 shares.
- Exercise price set at $0.53 per share (closing price on Feb 5, 2026).
- Vesting: 25% after one year, remainder pro rata over next 36 months; options expire 10 years from award date.
- Options granted under Envoy Medical's 2023 Equity Incentive Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026014878/0001213900-26-014878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026014878/ea0276618-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-014878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer